
Mohammad S. Rostami
Examiner (ID: 14480, Phone: (571)270-1980 , Office: P/2154 )
| Most Active Art Unit | 2154 |
| Art Unit(s) | 2169, 2156, 2154 |
| Total Applications | 706 |
| Issued Applications | 452 |
| Pending Applications | 73 |
| Abandoned Applications | 208 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1392351
[patent_doc_number] => 06544972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Methods of limiting apoptosis of cells'
[patent_app_type] => B1
[patent_app_number] => 09/509309
[patent_app_country] => US
[patent_app_date] => 2000-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 39
[patent_no_of_words] => 16442
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09509309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/509309 | Methods of limiting apoptosis of cells | Aug 14, 2000 | Issued |
| 09/640098 | Method for treating restless leg syndrome using pramipexole and clonidine | Aug 14, 2000 | Abandoned |
Array
(
[id] => 1374542
[patent_doc_number] => 06562859
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation'
[patent_app_type] => B1
[patent_app_number] => 09/555733
[patent_app_country] => US
[patent_app_date] => 2000-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8276
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562859.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555733 | Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation | Aug 3, 2000 | Issued |
Array
(
[id] => 1270980
[patent_doc_number] => 06653322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Therapeutic combinations of RAR antagonists and RXR agonists and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/619308
[patent_app_country] => US
[patent_app_date] => 2000-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 13750
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09619308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/619308 | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | Jul 18, 2000 | Issued |
Array
(
[id] => 1602775
[patent_doc_number] => 06432954
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Pharmaceutical compositions and methods for use'
[patent_app_type] => B1
[patent_app_number] => 09/616743
[patent_app_country] => US
[patent_app_date] => 2000-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16612
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432954.pdf
[firstpage_image] =>[orig_patent_app_number] => 09616743
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/616743 | Pharmaceutical compositions and methods for use | Jul 13, 2000 | Issued |
Array
(
[id] => 1601122
[patent_doc_number] => 06476042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-05
[patent_title] => 'Combination therapy for the treatment of migraine'
[patent_app_type] => B1
[patent_app_number] => 09/603630
[patent_app_country] => US
[patent_app_date] => 2000-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27866
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3504
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/476/06476042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09603630
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/603630 | Combination therapy for the treatment of migraine | Jun 25, 2000 | Issued |
Array
(
[id] => 4327585
[patent_doc_number] => 06329423
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Stable liquid formulations of high vitamin E content'
[patent_app_type] => 1
[patent_app_number] => 9/590804
[patent_app_country] => US
[patent_app_date] => 2000-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 903
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329423.pdf
[firstpage_image] =>[orig_patent_app_number] => 590804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/590804 | Stable liquid formulations of high vitamin E content | Jun 8, 2000 | Issued |
Array
(
[id] => 4410193
[patent_doc_number] => 06300359
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => '(E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4 -yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt'
[patent_app_type] => 1
[patent_app_number] => 9/581066
[patent_app_country] => US
[patent_app_date] => 2000-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2883
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300359.pdf
[firstpage_image] =>[orig_patent_app_number] => 581066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581066 | (E)-3-[1-n-Butyl-5-[2-(2-carboxyphenyl)methoxy-4-chlorophenyl]-1H-pyrazol-4 -yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl)methyl]-prop-2-enoic acid monoargininyl salt | Jun 7, 2000 | Issued |
Array
(
[id] => 4397512
[patent_doc_number] => 06297287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-02
[patent_title] => 'Anti-arrhythmic composition and methods of treatment'
[patent_app_type] => 1
[patent_app_number] => 9/588706
[patent_app_country] => US
[patent_app_date] => 2000-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4701
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/297/06297287.pdf
[firstpage_image] =>[orig_patent_app_number] => 588706
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/588706 | Anti-arrhythmic composition and methods of treatment | Jun 6, 2000 | Issued |
Array
(
[id] => 1383887
[patent_doc_number] => 06544515
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Acceleration of the rate of digestion of a protein'
[patent_app_type] => B1
[patent_app_number] => 09/588650
[patent_app_country] => US
[patent_app_date] => 2000-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6417
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544515.pdf
[firstpage_image] =>[orig_patent_app_number] => 09588650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/588650 | Acceleration of the rate of digestion of a protein | Jun 6, 2000 | Issued |
Array
(
[id] => 1068825
[patent_doc_number] => 06844351
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-18
[patent_title] => 'Corticotropin releasing factor antagonists'
[patent_app_type] => utility
[patent_app_number] => 09/583372
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67657
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844351.pdf
[firstpage_image] =>[orig_patent_app_number] => 09583372
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/583372 | Corticotropin releasing factor antagonists | May 30, 2000 | Issued |
Array
(
[id] => 699751
[patent_doc_number] => 07067664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-27
[patent_title] => 'Corticotropin releasing factor antagonists'
[patent_app_type] => utility
[patent_app_number] => 09/580281
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67857
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580281
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580281 | Corticotropin releasing factor antagonists | May 29, 2000 | Issued |
Array
(
[id] => 637926
[patent_doc_number] => 07125880
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-24
[patent_title] => 'Corticotropin releasing factor antagonists'
[patent_app_type] => utility
[patent_app_number] => 09/580287
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67848
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125880.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580287
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580287 | Corticotropin releasing factor antagonists | May 29, 2000 | Issued |
Array
(
[id] => 956296
[patent_doc_number] => 06956047
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-10-18
[patent_title] => 'Corticotropin releasing factor antagonists'
[patent_app_type] => utility
[patent_app_number] => 09/580791
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67858
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/956/06956047.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580791
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580791 | Corticotropin releasing factor antagonists | May 29, 2000 | Issued |
Array
(
[id] => 4269126
[patent_doc_number] => 06306858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Zwitterionic fatty acid compounds for anti-inflammation'
[patent_app_type] => 1
[patent_app_number] => 9/555278
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2352
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306858.pdf
[firstpage_image] =>[orig_patent_app_number] => 555278
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555278 | Zwitterionic fatty acid compounds for anti-inflammation | May 25, 2000 | Issued |
| 09/579564 | Calcium receptor-active molecules | May 25, 2000 | Abandoned |
Array
(
[id] => 1564254
[patent_doc_number] => 06375990
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Method and devices for transdermal delivery of lithium'
[patent_app_type] => B1
[patent_app_number] => 09/529248
[patent_app_country] => US
[patent_app_date] => 2000-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 7216
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/375/06375990.pdf
[firstpage_image] =>[orig_patent_app_number] => 09529248
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529248 | Method and devices for transdermal delivery of lithium | May 23, 2000 | Issued |
Array
(
[id] => 1528520
[patent_doc_number] => 06479553
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Use of certain affinity NMDA antagonists as antidepressants'
[patent_app_type] => B1
[patent_app_number] => 09/554315
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1599
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479553.pdf
[firstpage_image] =>[orig_patent_app_number] => 09554315
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554315 | Use of certain affinity NMDA antagonists as antidepressants | May 11, 2000 | Issued |
Array
(
[id] => 4353163
[patent_doc_number] => 06291482
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'N-hydroxyurea derivative and pharmaceutical composition containing the same'
[patent_app_type] => 1
[patent_app_number] => 9/554226
[patent_app_country] => US
[patent_app_date] => 2000-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3563
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291482.pdf
[firstpage_image] =>[orig_patent_app_number] => 554226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554226 | N-hydroxyurea derivative and pharmaceutical composition containing the same | May 10, 2000 | Issued |
Array
(
[id] => 4338134
[patent_doc_number] => 06333345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Methods of using and compositions comprising N-desmethylzolpidem'
[patent_app_type] => 1
[patent_app_number] => 9/563858
[patent_app_country] => US
[patent_app_date] => 2000-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6999
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333345.pdf
[firstpage_image] =>[orig_patent_app_number] => 563858
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563858 | Methods of using and compositions comprising N-desmethylzolpidem | May 3, 2000 | Issued |